“The Trump administration pulled one of its key proposals to lower drug prices that would have eliminated rebates to middlemen in Medicare, which President Trump’s top health official had touted as one of the most significant changes to curb medicine costs for consumers,” the Washington Post reports.
“The rule is the second major drug pricing effort to get blocked this week, complicating the administration’s efforts to make lowering prescription medicine costs a key 2020 presidential campaign issue.”
